Literature DB >> 925747

Embolism to the central nervous system from cardiac myxoma. Report of two cases.

B K Tipton, J T Robertson, J H Robertson.   

Abstract

Two cases of left atrial myxoma are reviewed, both presenting as embolic phenomena. Neither patient gave a history compatible with pre-existent cardiac dysfunction. Sudden collapse and subsequent right hemiplegia resulted in one patient when an embolus lodged in the left middle cerebral artery. The second patient presented with headache and transient visual obscuration in the left eye. She showed evidence of embolism to the central retinal artery, and particulate matter could be seen within the retinal arterioles. Attention is drown to the fact that echocardiography now constitutes a simple, noninvasive, and highly reliable method of making this diagnosis. The propensity for embolic tumor fragments to grow and invade cerebral arterial walls is discussed along with its possible neurosurgical significance.

Entities:  

Mesh:

Year:  1977        PMID: 925747     DOI: 10.3171/jns.1977.47.6.0937

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  4 in total

1.  Cranial MRI and CT in patients with left atrial myxoma.

Authors:  E Hofmann; T Becker; R Romberg-Hahnloser; H Reichmann; M Warmuth-Metz; M Nadjmi
Journal:  Neuroradiology       Date:  1992       Impact factor: 2.804

Review 2.  Neurological long-term follow-up in left atrial myxoma: are late complications frequent or rare?

Authors:  H Reichmann; R Romberg-Hahnloser; E Hofmann; T Becker; H G Mertens
Journal:  J Neurol       Date:  1992-03       Impact factor: 4.849

3.  Left atrial metastasis presenting as recurrent embolic strokes.

Authors:  N Chalmers; I W Campbell
Journal:  Br Heart J       Date:  1987-08

Review 4.  Rare presentation of an atrial myxoma in an adolescent patient: a case report and literature review.

Authors:  Eduardo Macias; Elizabeth Nieman; Kentaro Yomogida; Orlando Petrucci; Cylen Javidan; Kevin Baszis; Shafkat Anwar
Journal:  BMC Pediatr       Date:  2018-11-28       Impact factor: 2.125

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.